Correlation Between GM and Eupraxia Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both GM and Eupraxia Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GM and Eupraxia Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between General Motors and Eupraxia Pharmaceuticals Common, you can compare the effects of market volatilities on GM and Eupraxia Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GM with a short position of Eupraxia Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of GM and Eupraxia Pharmaceuticals.
Diversification Opportunities for GM and Eupraxia Pharmaceuticals
0.69 | Correlation Coefficient |
Poor diversification
The 3 months correlation between GM and Eupraxia is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding General Motors and Eupraxia Pharmaceuticals Commo in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eupraxia Pharmaceuticals and GM is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on General Motors are associated (or correlated) with Eupraxia Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eupraxia Pharmaceuticals has no effect on the direction of GM i.e., GM and Eupraxia Pharmaceuticals go up and down completely randomly.
Pair Corralation between GM and Eupraxia Pharmaceuticals
Allowing for the 90-day total investment horizon GM is expected to generate 2.14 times less return on investment than Eupraxia Pharmaceuticals. But when comparing it to its historical volatility, General Motors is 2.17 times less risky than Eupraxia Pharmaceuticals. It trades about 0.1 of its potential returns per unit of risk. Eupraxia Pharmaceuticals Common is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 260.00 in Eupraxia Pharmaceuticals Common on September 2, 2024 and sell it today you would earn a total of 75.00 from holding Eupraxia Pharmaceuticals Common or generate 28.85% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
General Motors vs. Eupraxia Pharmaceuticals Commo
Performance |
Timeline |
General Motors |
Eupraxia Pharmaceuticals |
GM and Eupraxia Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with GM and Eupraxia Pharmaceuticals
The main advantage of trading using opposite GM and Eupraxia Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GM position performs unexpectedly, Eupraxia Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eupraxia Pharmaceuticals will offset losses from the drop in Eupraxia Pharmaceuticals' long position.The idea behind General Motors and Eupraxia Pharmaceuticals Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Eupraxia Pharmaceuticals vs. Dogwood Therapeutics, | Eupraxia Pharmaceuticals vs. Enanta Pharmaceuticals | Eupraxia Pharmaceuticals vs. Enveric Biosciences | Eupraxia Pharmaceuticals vs. ESSA Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Transaction History View history of all your transactions and understand their impact on performance |